The latest update is out from Noronex Ltd. ( (AU:NRX) ).
Noronex Limited announced a change in the director’s interest, specifically involving James Thompson. The change involved the exercise of unquoted options, resulting in the acquisition of 7,608,528 fully paid ordinary shares and the disposal of the same number of unquoted options. This transaction reflects a strategic adjustment in the director’s holdings, potentially impacting the company’s share distribution and signaling confidence in the company’s future prospects.
More about Noronex Ltd.
YTD Price Performance: 45.45%
Average Trading Volume: 1,537,456
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$8.24M
Learn more about NRX stock on TipRanks’ Stock Analysis page.